OTO Fertility has launched what it claims is a world-first AI fertility prediction platform and wearable to forecast treatment outcomes. The Toronto-based company says its system...
Megestrol, a hot flush drug for breast cancer patients, may also curb tumours when added to standard hormone therapy, an early trial has found. The PIONEER...
Femtech World explores the latest business developments in the world of women’s health. FemHealth Ventures closes oversubscribed US$65m Fund II FemHealth Ventures, a women’s health-focused venture...
A petition calling on the UK government to introduce menstrual leave for women with gynaecological conditions has gathered nearly 75,000 signatures. The campaign needs 100,000 signatures...
By Ruby Raut, founder and CEO, WUKA If you have ever noticed that your cramps feel sharper, your mood dips harder, or your energy seems to...
By Ruby Raut, founder and CEO, WUKA When we think of period products, the usual concerns are comfort, absorbency, cost and maybe sustainability. But there is...
With delayed parenthood now the norm, a new wave of biotech innovators is targeting the root cause of rising infertility rates. Oxford-based startup U-Ploid tells Femtech...
By Ruby Raut, founder and CEO, WUKA Over the past year, headlines about “toxic period products” have been hard to ignore. Stories about PFAS, heavy metals,...
Women experience slightly worse recovery than men in the first year after stroke, with more difficulty with daily tasks such as eating, dressing and driving. The...
Caesarean births (surgical births) have overtaken vaginal deliveries in England for the first time, with 45 per cent of births now by caesarean, NHS data show....
